483 Grifols Therapeutics Dec 2018

483 Grifols Therapeutics Dec 2018

$119 - Not in Stock

FDA investigators audited the Grifols Therapeutics - Clayton, NC, United States facility and issued inspectional observations (via FDA 483) on 13 Dec 2018.

Product details

  • Category: Biologics
  • Inspection end: 13 Dec 2018
  • Location: Clayton, United States
  • FEI: 1050373
Order